WSTAM
BSX icon

Wilbanks Smith & Thomas Asset Management’s Boston Scientific BSX Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-500
Closed -$19K – 475
2018
Q3 		$19K Buy
+500
New +$17.5K ﹤0.01% 893

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's BSX Position: Q4 2018 in Review

Wilbanks Smith & Thomas Asset Management sold out of Boston Scientific (BSX) in Q4 2018, closing a stake of 500 shares — an estimated $19K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in BSX in Q3 2018 and held it in 1 quarter. The position peaked at $19K in Q3 2018. 730 funds tracked by Wall St. Rank hold BSX as of Q4 2018.

  • Wilbanks Smith & Thomas Asset Management reported no remaining Boston Scientific position as of Q4 2018 after selling out during the quarter.
  • Wilbanks Smith & Thomas Asset Management sold 500 Boston Scientific shares in Q4 2018, an estimated $19K.
  • Wilbanks Smith & Thomas Asset Management first reported a position in Boston Scientific in Q3 2018 and held it in 1 quarter.
  • Wilbanks Smith & Thomas Asset Management's Boston Scientific position peaked at $19K in Q3 2018.
  • 730 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2018.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.